title: First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate.
authors.affiliation: Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
authors.forename: Ahmet Emre
authors.initials: AE
authors.lastname: Eskazan
authors.forename: Mesut
authors.initials: M
authors.lastname: Ayer
authors.forename: Bulent
authors.initials: B
authors.lastname: Kantarcioglu
authors.forename: Deniz
authors.initials: D
authors.lastname: Arica
authors.forename: Naciye
authors.initials: N
authors.lastname: Demirel
authors.forename: Demet
authors.initials: D
authors.lastname: Aydin
authors.forename: Fevzi Firat
authors.initials: FF
authors.lastname: Yalniz
authors.forename: Tugrul
authors.initials: T
authors.lastname: Elverdi
authors.forename: Ayse
authors.initials: A
authors.lastname: Salihoglu
authors.forename: Muhlis Cem
authors.initials: MC
authors.lastname: Ar
authors.forename: Seniz
authors.initials: S
authors.lastname: Ongoren Aydin
authors.forename: Zafer
authors.initials: Z
authors.lastname: Baslar
authors.forename: Yildiz
authors.initials: Y
authors.lastname: Aydin
authors.forename: Nukhet
authors.initials: N
authors.lastname: Tuzuner
authors.forename: Ugur
authors.initials: U
authors.lastname: Ozbek
authors.forename: Teoman
authors.initials: T
authors.lastname: Soysal
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D006801:Humans; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate
keywords: chronic myeloid leukaemia; efficacy; generic; imatinib mesylate